Filing Details
- Accession Number:
- 0001181431-11-031634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-20 16:31:46
- Reporting Period:
- 2011-05-18
- Filing Date:
- 2011-05-20
- Accepted Time:
- 2011-05-20 16:31:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484478 | Furiex Pharmaceuticals Inc. | FURX | Pharmaceutical Preparations (2834) | 271197863 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033409 | N Fredric Eshelman | C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-18 | 12,599 | $14.52 | 604,088 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-05-19 | 12,599 | $14.12 | 616,687 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-05-20 | 465,000 | $13.99 | 1,081,687 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 41,666 | Indirect | GRAT |
| Common Stock | 938 | Indirect | LLC |
| Common Stock | 140 | Indirect | Spouse |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | $9.11 | 2020-06-17 | 197,627 | 197,627 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-06-17 | 197,627 | 197,627 | Indirect |
Footnotes
- The options were awarded on 6/17/2010 and vest and become exercisable over three years, with one-third of the Option vesting on each of the first, second and third anniversaries of the date of grant, provided that the Optionee's consulting relationship with the Company continues.
Billionaire Hedge Funds
